Prohibition Partners · Free weekly briefing
International Cannabis Weekly
The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.
400
6 regions31 stories22 publishers15 countries
Top story
Medical cannabis showdown: UK vs Germany – product variety and pricing compared
Over the last decade, the European medical cannabis landscape has seen a significant surge of new products entering the market, providing patients, especially in the UK and Germany, with greater variety than ever before.
- 01
Swiss pilot study finds legalisation reduces problematic cannabis use
Cannabis HealthCHAdult-use
- 02
Five EU countries finalise reforms as medical cannabis access expands
Business of CannabisEUMedical
Europe
6 stories- Medical cannabis now available in one in seven pharmacies across Germany
Hanf MagazinDEMedical
- Dutch grower The Growery confirms production start in regulated cannabis trial
Cannabis IndustrieNLAdult-use
- Curaleaf secures EU medical device certification for cannabis vaporisers
Cannabis Business TimesEUMedical
- Oxford Cannabinoid Technologies has collapsed
Business of CannabisGBBusiness & Investment
- CBD flower distributors in Austria face crisis following legal reclassification
SechatATHemp & CBD
- European cannabis businesses off to flying start in 2025 with business booming in Q1
Business of CannabisEUBusiness & Investment
United States
6 stories- Missouri Supreme Court hears case on stacked cannabis taxes by local jurisdictions
Marijuana MomentUSRegulation
- Cannabis tax revenues redirected to support universal basic income programme
leafieUSRegulation
- Michigan cannabis sales dip in April amid falling prices and market shifts
New Cannabis VenturesUSBusiness & Investment
- Hemp fibre sector remains optimistic despite structural hurdles, report finds
HempTodayUSHemp & CBD
- TerrAscend expands retail presence with new dispensary acquisitions
MJBizDailyUSBusiness & Investment
- New York suspends sales of select cannabis products over inversion concerns
MJBizDailyUSRegulation
Canada
5 stories- Greenway targets six annual crop rotations in latest market update for 2025
Cannabis Business TimesCABusiness & Investment
- Boston Beer expands cannabis beverages range ahead of summer sales
GlobeNewswireCABusiness & Investment
- Organigram ponders global expansion push after record-breaking quarter
BNN BloombergCABusiness & Investment
- Village Farms observes rise in international sales, decline in branded revenues
StratCannCABusiness & Investment
- GrowerIQ selected for Canadian trade mission to South-East Asia
ReutersCABusiness & Investment
LATAM & Caribbean
4 stories- Brazil to host major medical cannabis congress bringing together advocates
Business of CannabisBREvents & Industry
- Argentina's INASE and ARICCAME unveil 2025 hemp registry updates
El PlanteoARHemp & CBD
- UNAM expands commitment to advancing medical cannabis research through new initiatives
oem.com.mxMXMedical
- Former Uruguayan president José Mujica reflects on cannabis legalisation legacy
excelsior.com.mxUYRegulation
Africa & Middle East
4 stories- Lebanon reignites cannabis debate believing it could be economic saviour
lbcgroup.tvLBRegulation
- New cannabis laws expected soon in South Africa to expand regulatory landscape
BusinessTechZARegulation
- KZN launches new cannabis processing initiative to boost employment
IOLZABusiness & Investment
- Kenya ponders cannabis legalisation amid economic and social concerns
kahawatungu.comKERegulation
Oceania
3 stories- Ecofibre secures emergency $4M loan as financial pressures mount
CannabizAUBusiness & Investment
- Vitura Health forecasts strong fourth quarter after challenging year
CannabizAUBusiness & Investment
- Australian cannabis sector struggles amid import pressures
StratCannAUBusiness & Investment
Never miss an issue
International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.
From the research library
Global Medical Cannabis Market Review
14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.
From £1,265
View report